Evidence map›Paper›PMID 30060767›Full record

ReviewVeterinary research2018

Innovative drugs, chemicals, and enzymes within the animal production chain.

Yousef I Hassan, Ludovic Lahaye, Max M Gong, Jian Peng, Joshua Gong, Song Liu, Cyril G Gay, Chengbo Yang

Open access · goldAbstract readReview
In one paragraph

Review in Veterinary research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Post-weaning diarrhea and use of feedstuffs in pigs.Animal frontiers : the review magazine of animal agriculture · 2022
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Yousef I HassanGuelph Research and Development Centre, Agriculture and Agri-Food Canada, Guelph, ON, Canada.
Ludovic LahayeJefo Nutrition Inc., Saint-Hyacinthe, QC, Canada.
Max M GongDepartment of Biomedical Engineering, Wisconsin Institutes for Medical Research, University of Wisconsin-Madison, 1111 Highland Avenue, Madison, WI, 53705, USA.
Jian PengCollege of Animal Science, Huazhong Agricultural University, Wuhan, China.
Joshua GongGuelph Research and Development Centre, Agriculture and Agri-Food Canada, Guelph, ON, Canada.
Song LiuDepartment of Biosystems Engineering, University of Manitoba, Winnipeg, MB, Canada.
Cyril G GayOffice of National Programs, Animal Production and Protection, Agricultural Research Service, US Department of Agriculture, Beltsville, MD, 20705, USA.
Chengbo YangDepartment of Animal Science, University of Manitoba, Winnipeg, MB, Canada. chengbo.yang@umanitoba.ca.
Agriculture and Agri-Food Canada · CAUniversity of Manitoba · CAHuazhong Agricultural University · CNUnited States Department of Agriculture · USWisconsin Institutes for Discovery · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The alarming number of recently reported human illnesses with bacterial infections resistant to multiple antibacterial agents has become a serious concern in recent years. This phenomenon is a core challenge for both the medical and animal health communities, since the use of antibiotics has formed the cornerstone of modern medicine for treating bacterial infections. The empirical benefits of using antibiotics to address animal health issues in animal agriculture (using therapeutic doses) and increasing the overall productivity of animals (using sub-therapeutic doses) are well established. The use of antibiotics to enhance profitability margins in the animal production industry is still practiced worldwide. Although many technical and economic reasons gave rise to these practices, the continued emergence of antimicrobial resistant bacteria is furthering the need to reduce the use of medically important antibiotics. This will require improving on-farm management and biosecurity practices, and the development of effective antibiotic alternatives that will reduce the dependence on antibiotics within the animal industry in the foreseeable future. A number of approaches are being closely scrutinized and optimized to achieve this goal, including the development of promising antibiotic alternatives to control bacterial virulence through quorum-sensing disruption, the use of synthetic polymers and nanoparticles, the exploitation of recombinant enzymes/proteins (such as glucose oxidases, alkaline phosphatases and proteases), and the use of phytochemicals. This review explores the most recent approaches within this context and provides a summary of practical mitigation strategies for the extensive use of antibiotics within the animal production chain in addition to several future challenges that need to be addressed.

Indexed as

Animal DiseasesAnimal HusbandryAnimalsAnti-Bacterial AgentsBacteriaBacterial InfectionsAnti-Bacterial Agents

Identifiers

PMID30060767
PMCPMC6066918
OpenAlexW2884191253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.